![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 26, 27239-27245, June 25, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


||

From the
Cancer Research UK and University of Manchester, Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX and the ¶School of Biological Sciences, 1.800 Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom
Elucidation of the molecular structure of heparan sulfate (HS) is the key to understanding its functional versatility as a co-receptor for growth factors and morphogens. We have identified and exploited the novel substrate specificity of the coliphage K5 lyase in studies of the domain organization of HS. We show that K5 lyase cleaves HS principally within non-sulfated sequences of four or more N-acetylated disaccharides. Uniquely, sections comprising alternating N-acetylated and N-sulfated units are resistant to the enzyme, as are the highly sulfated S domains. Spacing of the K5 lyase cleavage sites (
78 kDa) is similar to that of the S domains. On the basis of these findings, we propose a refined model of the structure of HS in which N-acetylated sequences of four to five disaccharide units (GlcNAc-GlcUA)45 are positioned centrally between the S domains. The latter are embedded within N-acetylated and N-sulfated sequences, forming extended regions of hypervariable sulfation distributed at regular intervals along the polymer chain. K5 lyase provides a means of excision of these composite sulfated regions for structural and functional analyses.
Received for publication, February 18, 2004 , and in revised form, March 24, 2004.
* This work was funded by grants from Cancer Research UK, Matrix Therapeutics, and the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: The School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK.
|| To whom correspondence should be addressed. E-mail: cmerry{at}picr.man.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. C. Lamanna, M.-A. Frese, M. Balleininger, and T. Dierks Sulf Loss Influences N-, 2-O-, and 6-O-Sulfation of Multiple Heparan Sulfate Proteoglycans and Modulates Fibroblast Growth Factor Signaling J. Biol. Chem., October 10, 2008; 283(41): 27724 - 27735. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Carlsson, J. Presto, D. Spillmann, U. Lindahl, and L. Kjellen Heparin/Heparan Sulfate Biosynthesis: PROCESSIVE FORMATION OF N-SULFATED DOMAINS J. Biol. Chem., July 18, 2008; 283(29): 20008 - 20014. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Crublet, J.-P. Andrieu, R. R. Vives, and H. Lortat-Jacob The HIV-1 Envelope Glycoprotein gp120 Features Four Heparan Sulfate Binding Domains, Including the Co-receptor Binding Site J. Biol. Chem., May 30, 2008; 283(22): 15193 - 15200. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Catlow, J. A. Deakin, Z. Wei, M. Delehedde, D. G. Fernig, E. Gherardi, J. T. Gallagher, M. S. G. Pavao, and M. Lyon Interactions of Hepatocyte Growth Factor/Scatter Factor with Various Glycosaminoglycans Reveal an Important Interplay between the Presence of Iduronate and Sulfate Density J. Biol. Chem., February 29, 2008; 283(9): 5235 - 5248. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tissot, N. Gasiunas, A. K Powell, Y. Ahmed, Z.-l. Zhi, S. M Haslam, H. R Morris, J. E Turnbull, J. T Gallagher, and A. Dell Towards GAG glycomics: Analysis of highly sulfated heparins by MALDI-TOF mass spectrometry Glycobiology, September 1, 2007; 17(9): 972 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Johnson, B. E. Crawford, M. Stavridis, G. ten Dam, A. L. Wat, G. Rushton, C. M. Ward, V. Wilson, T. H. van Kuppevelt, J. D. Esko, et al. Essential Alterations of Heparan Sulfate During the Differentiation of Embryonic Stem Cells to Sox1-Enhanced Green Fluorescent Protein-Expressing Neural Progenitor Cells Stem Cells, August 1, 2007; 25(8): 1913 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Herbert, J. A. Deakin, C. Q. Schmidt, B. S. Blaum, C. Egan, V. P. Ferreira, M. K. Pangburn, M. Lyon, D. Uhrin, and P. N. Barlow Structure Shows That a Glycosaminoglycan and Protein Recognition Site in Factor H Is Perturbed by Age-related Macular Degeneration-linked Single Nucleotide Polymorphism J. Biol. Chem., June 29, 2007; 282(26): 18960 - 18968. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mahalingam, J. T. Gallagher, and J. R. Couchman Cellular Adhesion Responses to the Heparin-binding (HepII) Domain of Fibronectin Require Heparan Sulfate with Specific Properties J. Biol. Chem., February 2, 2007; 282(5): 3221 - 3230. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kreuger, D. Spillmann, J.-p. Li, and U. Lindahl Interactions between heparan sulfate and proteins: the concept of specificity J. Cell Biol., July 31, 2006; 174(3): 323 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Clamp, F. H. Blackhall, A. Henrioud, G. C. Jayson, K. Javaherian, J. Esko, J. T. Gallagher, and C. L. R. Merry The Morphogenic Properties of Oligomeric Endostatin Are Dependent on Cell Surface Heparan Sulfate J. Biol. Chem., May 26, 2006; 281(21): 14813 - 14822. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ai, A.-T. Do, M. Kusche-Gullberg, U. Lindahl, K. Lu, and C. P. Emerson Jr. Substrate Specificity and Domain Functions of Extracellular Heparan Sulfate 6-O-Endosulfatases, QSulf1 and QSulf2 J. Biol. Chem., February 24, 2006; 281(8): 4969 - 4976. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Robinson, B. Mulloy, J. T. Gallagher, and S. E. Stringer VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase J. Biol. Chem., January 20, 2006; 281(3): 1731 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Robinson, N. J. Harmer, S. J. Goodger, T. L. Blundell, and J. T. Gallagher Cooperative Dimerization of Fibroblast Growth Factor 1 (FGF1) upon a Single Heparin Saccharide May Drive the Formation of 2:2:1 FGF1{middle dot}FGFR2c{middle dot}Heparin Ternary Complexes J. Biol. Chem., December 23, 2005; 280(51): 42274 - 42282. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Hindson, J. T. Gallagher, W. Halfter, and P. N. Bishop Opticin Binds to Heparan and Chondroitin Sulfate Proteoglycans Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4417 - 4423. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sarrazin, D. Bonnaffe, A. Lubineau, and H. Lortat-Jacob Heparan Sulfate Mimicry: A SYNTHETIC GLYCOCONJUGATE THAT RECOGNIZES THE HEPARIN BINDING DOMAIN OF INTERFERON-{gamma} INHIBITS THE CYTOKINE ACTIVITY J. Biol. Chem., November 11, 2005; 280(45): 37558 - 37564. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Cain, C. Baldock, J. Gallagher, A. Morgan, D. V. Bax, A. S. Weiss, C. A. Shuttleworth, and C. M. Kielty Fibrillin-1 Interactions with Heparin: IMPLICATIONS FOR MICROFIBRIL AND ELASTIC FIBER ASSEMBLY J. Biol. Chem., August 26, 2005; 280(34): 30526 - 30537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van den Born, K. Salmivirta, T. Henttinen, N. Ostman, T. Ishimaru, S. Miyaura, K. Yoshida, and M. Salmivirta Novel Heparan Sulfate Structures Revealed by Monoclonal Antibodies J. Biol. Chem., May 27, 2005; 280(21): 20516 - 20523. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wei, M. Lyon, and J. T. Gallagher Distinct Substrate Specificities of Bacterial Heparinases against N-Unsubstituted Glucosamine Residues in Heparan Sulfate J. Biol. Chem., April 22, 2005; 280(16): 15742 - 15748. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. West, C. G. Rees, L. Duchesne, S. J. Patey, C. J. Terry, J. E. Turnbull, M. Delehedde, C. W. Heegaard, F. Allain, C. Vanpouille, et al. Interactions of Multiple Heparin Binding Growth Factors with Neuropilin-1 and Potentiation of the Activity of Fibroblast Growth Factor-2 J. Biol. Chem., April 8, 2005; 280(14): 13457 - 13464. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sadir, A. Imberty, F. Baleux, and H. Lortat-Jacob Heparan Sulfate/Heparin Oligosaccharides Protect Stromal Cell-derived Factor-1 (SDF-1)/CXCL12 against Proteolysis Induced by CD26/Dipeptidyl Peptidase IV J. Biol. Chem., October 15, 2004; 279(42): 43854 - 43860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ledin, W. Staatz, J.-P. Li, M. Gotte, S. Selleck, L. Kjellen, and D. Spillmann Heparan Sulfate Structure in Mice with Genetically Modified Heparan Sulfate Production J. Biol. Chem., October 8, 2004; 279(41): 42732 - 42741. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. ten Dam, E. M. A. van de Westerlo, T. F. C. M. Smetsers, M. Willemse, G. N. P. van Muijen, C. L. R. Merry, J. T. Gallagher, Y. S. Kim, and T. H. van Kuppevelt Detection of 2-O-Sulfated Iduronate and N-Acetylglucosamine Units in Heparan Sulfate by an Antibody Selected against Acharan Sulfate (IdoA2S-GlcNAc)n J. Biol. Chem., September 10, 2004; 279(37): 38346 - 38352. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |